Profile picture

Doctor Tuukka Tarvasmaki

Helsinki University Hospital, Helsinki (Finland)
Follow
Logo ESC

Contributor content

Prognostic value of proenkephalin in mortality prediction in cardiogenic shock
Presentation
Prognostic value of proenkephalin in mortality prediction in cardiogenic shock
Read more
Hemodynamic alterations and 90-day mortality in cardiogenic shock complicated by acute kidney injury
Presentation
Hemodynamic alterations and 90-day mortality in cardiogenic shock complicated by acute kidney injury
Read more
Effect of baseline characteristics on mortality in the SURVIVE trial comparing levosimendan and dobutamine in acute heart failure: sub-analysis of the Finnish patients
Presentation
Effect of baseline characteristics on mortality in the SURVIVE trial comparing levosimendan and dobutamine in acute heart failure: sub-analysis of the Finnish patients
Read more
Adrenaline use is related to prominent deterioration in cardiac and renal biomarker profiles in cardiogenic shock
Presentation
Adrenaline use is related to prominent deterioration in cardiac and renal biomarker profiles in cardiogenic shock
Read more
Noradrenaline combined with either dobutamine or levosimendan - similar outcome and cardiac biomarker evolution in cardiogenic shock
Presentation
Noradrenaline combined with either dobutamine or levosimendan - similar outcome and cardiac biomarker evolution in cardiogenic shock
Read more

ESC 365 is supported by

novartis Explore sponsored resources